148 related articles for article (PubMed ID: 26146667)
21. Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors: A Randomized Clinical Trial.
Nissen SE; Wolski KE; Prcela L; Wadden T; Buse JB; Bakris G; Perez A; Smith SR
JAMA; 2016 Mar; 315(10):990-1004. PubMed ID: 26954408
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and determinants of metabolic syndrome among newly diagnosed type 2 diabetic subjects according to different criteria.
Hossain S; Fatema K; Ahmed KR; Akter J; Chowdhury HA; Shahjahan M; Acharyya A; Rahim MA; Ali L
Diabetes Metab Syndr; 2015; 9(2):120-3. PubMed ID: 25470642
[TBL] [Abstract][Full Text] [Related]
23. Body mass index, gender, and clinical outcome among hypertensive and diabetic patients with stage A/B heart failure.
Ballo P; Betti I; Barchielli A; Castelli G; De Luca L; Gheorghiade M; Zuppiroli A
Obesity (Silver Spring); 2013 Sep; 21(9):E500-7. PubMed ID: 23512886
[TBL] [Abstract][Full Text] [Related]
24. Can we reconcile 'the obesity paradox' with recent cardiovascular outcome trials in diabetes?
Jamieson A; Finer N
Clin Obes; 2017 Oct; 7(5):255-259. PubMed ID: 28877557
[No Abstract] [Full Text] [Related]
25. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study.
Grover SA; Kaouache M; Rempel P; Joseph L; Dawes M; Lau DC; Lowensteyn I
Lancet Diabetes Endocrinol; 2015 Feb; 3(2):114-22. PubMed ID: 25483220
[TBL] [Abstract][Full Text] [Related]
26. [Cardiovascular Epidemiologic Observatory: temporal trends of cardiovascular risk factors].
Palmieri L; Lo Noce C; Vanuzzo D; Dima F; Donfrancesco C; Pilotto L; Ciccarelli P; Giannelli AM; Vannucchi S; Laurendi G; Giampaoli S;
G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 3):31S-36S. PubMed ID: 20879476
[No Abstract] [Full Text] [Related]
27. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease.
Meigs JB; Wilson PW; Fox CS; Vasan RS; Nathan DM; Sullivan LM; D'Agostino RB
J Clin Endocrinol Metab; 2006 Aug; 91(8):2906-12. PubMed ID: 16735483
[TBL] [Abstract][Full Text] [Related]
28. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.
Song SH; Hardisty CA
QJM; 2008 Nov; 101(11):875-9. PubMed ID: 18776208
[TBL] [Abstract][Full Text] [Related]
29. Women's cardiovascular health: prevention is key.
Oertelt-Prigione S; Regitz-Zagrosek V
Arch Intern Med; 2009 Oct; 169(19):1740-1. PubMed ID: 19858428
[No Abstract] [Full Text] [Related]
30. Accelerometer-derived sedentary and physical activity time in overweight/obese adults with type 2 diabetes: cross-sectional associations with cardiometabolic biomarkers.
Healy GN; Winkler EA; Brakenridge CL; Reeves MM; Eakin EG
PLoS One; 2015; 10(3):e0119140. PubMed ID: 25775249
[TBL] [Abstract][Full Text] [Related]
31. NICE addresses the obesity epidemic.
Nurs Stand; 2014 Dec; 29(14):13. PubMed ID: 25467327
[No Abstract] [Full Text] [Related]
32. Fitness, fatness, and cardiovascular risk factors in type 2 diabetes: look ahead study.
Wing RR; Jakicic J; Neiberg R; Lang W; Blair SN; Cooper L; Hill JO; Johnson KC; Lewis CE;
Med Sci Sports Exerc; 2007 Dec; 39(12):2107-16. PubMed ID: 18046181
[TBL] [Abstract][Full Text] [Related]
33. Role of diabetes and obesity in outcomes of the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial.
Nakao K; Hirata M; Oba K; Yasuno S; Ueshima K; Fujimoto A; Ogihara T; Saruta T;
Hypertens Res; 2010 Jun; 33(6):600-6. PubMed ID: 20379187
[TBL] [Abstract][Full Text] [Related]
34. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
35. Body mass index and waist circumference predict both 10-year nonfatal and fatal cardiovascular disease risk: study conducted in 20,000 Dutch men and women aged 20-65 years.
van Dis I; Kromhout D; Geleijnse JM; Boer JM; Verschuren WM
Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):729-34. PubMed ID: 19809330
[TBL] [Abstract][Full Text] [Related]
36. Obesity and metabolic disease.
Koopman RJ; Swofford SJ; Beard MN; Meadows SE
Prim Care; 2009 Jun; 36(2):257-70. PubMed ID: 19501242
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome in subjects with type-2 diabetes mellitus.
Alebiosu CO; Odusan BO
J Natl Med Assoc; 2004 Jun; 96(6):817-21. PubMed ID: 15233492
[TBL] [Abstract][Full Text] [Related]
38. Overweight and obese cardiac patients have better prognosis despite reporting worse perceived health and more conventional risk factors.
Hamer M; Stamatakis E
Prev Med; 2013 Jul; 57(1):12-6. PubMed ID: 23480970
[TBL] [Abstract][Full Text] [Related]
39. Obesity paradox in outcomes of atrial fibrillation.
Badheka AO; Rathod A; Bharadwaj A; Afonso L; Jacob S
Am J Cardiol; 2011 Aug; 108(3):474. PubMed ID: 21757046
[No Abstract] [Full Text] [Related]
40. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity.
Caterson ID; Hubbard V; Bray GA; Grunstein R; Hansen BC; Hong Y; Labarthe D; Seidell JC; Smith SC;
Circulation; 2004 Nov; 110(18):e476-83. PubMed ID: 15520332
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
